1.
Kevin Gaffney, Michael Weinberg, Maira Soto, Stan Louie, Kathleen Rodgers. Development of angiotensin II (1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression. haematol [Internet]. 2018Nov.30 [cited 2024Nov.22];103(12):e567-e570. Available from: https://haematologica.org/article/view/8710